No Data
No Data
ELIQUENT Life Sciences Announces: Wendy Sanhai, Ph.D., MBA, Joins ELIQUENT Board of Directors
Johnson & Johnson Makes $15 Billion Bet on Mental-health Drugs
Illumina Launches Proteomics Pilot With 50,000 UK Biobank Samples, Partners With GSK, J&J, and Novartis
GlaxoSmithKline (GSK.US) will invest 1.15 billion USD to acquire IDRx to expand its cancer Business.
The UK pharmaceutical company GlaxoSmithKline announced on Monday that it will invest 1.15 billion USD to acquire the USA biotechnology company IDRx.
GSK to Buy US-based IDRx for Up to $1.15 Billion to Boost Gastrointestinal Cancer Pipeline
Press Release: GSK Enters Agreement to Acquire IDRx, Inc.
Youngman : okay what stocks should I keep an eye on in case this happenes?
Jaguar8 OP Youngman : Posted or tagged
Phuong999 : Which one the best ?
Jaguar8 OP Phuong999 : Hmm whichever gets news and buy pressure.
Deep Sea : U missed out Pfizer
View more comments...